BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J, Diamond EL. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018;131:2877-2890. [PMID: 29720485 DOI: 10.1182/blood-2018-03-839753] [Cited by in Crossref: 124] [Cited by in F6Publishing: 146] [Article Influence: 31.0] [Reference Citation Analysis]
Number Citing Articles
1 Francis JH, Gobin YP, Diamond EL. Treatment-Refractory Nodular Scleritis. JAMA Ophthalmol. [DOI: 10.1001/jamaophthalmol.2022.3591] [Reference Citation Analysis]
2 Li H, Li D, Xia J, Huang H, Jiao N, Zheng Z, Zhao Y, Guo X. Radiological features of Rosai-Dorfman disease: case series and review of the literature. Clin Radiol 2022:S0009-9260(22)00353-1. [PMID: 36038400 DOI: 10.1016/j.crad.2022.07.008] [Reference Citation Analysis]
3 Yu Q, Zhou HY, Wang X, Zhang YT. Intracranial Rosai-Dorfman disease with hypopituitarism and eventual death: A rare case report. Asian J Surg 2022:S1015-9584(22)01064-8. [PMID: 35961894 DOI: 10.1016/j.asjsur.2022.07.095] [Reference Citation Analysis]
4 Razanamahery J, Abdallahoui M, Chabridon G, Fromont A, Tarris G, Idbaih A, Comby PO, Godard F, Haroche J, Audia S, Bonnotte B. Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E -Mutated Erdheim-Chester Disease: A Case Report. Front Immunol 2022;13:918613. [PMID: 35874752 DOI: 10.3389/fimmu.2022.918613] [Reference Citation Analysis]
5 Yang PY, Ma XL, Zhao W, Fu LB, Zhang R, Zeng Q, Qin H, Yu T, Su Y. Malignant histiocytosis associated with mediastinal germ cell tumor: A case report . World J Clin Cases 2022; 10(20): 7116-7123 [DOI: 10.12998/wjcc.v10.i20.7116] [Reference Citation Analysis]
6 Pattenden TA, Morton A, Keller A. Xanthogranulomatous orchitis: A rare case of testicular mass. Urology Case Reports 2022;43:102111. [DOI: 10.1016/j.eucr.2022.102111] [Reference Citation Analysis]
7 Liu MM, Wangsiricharoen S, Dhar SI. Novel treatment options for subglottic stenosis in Rosai-Dorfman disease: A case report and review of the literature. Otolaryngology Case Reports 2022;23:100419. [DOI: 10.1016/j.xocr.2022.100419] [Reference Citation Analysis]
8 Amoako E, Danso KA, Akuaku RS, Ulzen-appiah K, Kasapcopur O. A Report of Rosai–Dorfman Disease in an Adolescent. Case Reports in Pediatrics 2022;2022:1-5. [DOI: 10.1155/2022/9571400] [Reference Citation Analysis]
9 Carroll AS, Doherty CM, Blake J, Hunt SJ, Hoskote C, McNicholl F, Phadke R, Sheehy O, Bremner FD, D'Sa S, McNamara C, Reilly MM. Neurology and the histiocytoses: a case of Rosai-Dorfman-Destombes disease. Pract Neurol 2022:practneurol-2022-003398. [PMID: 35534197 DOI: 10.1136/practneurol-2022-003398] [Reference Citation Analysis]
10 Gazia C, Giordano L, Diodoro MG, Compalati I, Avantifiori R, Grazi GL. Differential diagnosis in Rosai-Dorfman disease: A rare case of isolated hepatic presentation mimicking a metastatic tumor with positive 18-FDG uptake. Intractable Rare Dis Res 2022;11:90-2. [PMID: 35702580 DOI: 10.5582/irdr.2022.01037] [Reference Citation Analysis]
11 Zhu Q, Liang Y, Fan Z, Liu Y, Zhou C, Zhang H, Li T, Zhou Y, Yang J, Wang L. Management of central nervous system Rosai-Dorfman disease: A single center treatment experience. Journal of Clinical Neuroscience 2022;99:275-81. [DOI: 10.1016/j.jocn.2022.03.028] [Reference Citation Analysis]
12 Choi R, Ring N, Mcniff JM, Wilson LD, Martin K, Leventhal J. Treatment of multifocal cutaneous Rosai-Dorfman disease with radiotherapy. JAAD Case Reports 2022;23:106-8. [DOI: 10.1016/j.jdcr.2022.03.027] [Reference Citation Analysis]
13 Yazbeck M, Comair Y, Berjaoui C, Dabboucy B. Craniocervical Rosai-Dorfman Disease presentation: Case report and review of literature. Neurocirugía 2022. [DOI: 10.1016/j.neucir.2022.03.005] [Reference Citation Analysis]
14 Gonzales MR, White JC, Mangum DS, Powell JL. Sporadic extranodal Rosai-Dorfman-Destombes disease treated with tocilizumab. Pediatr Blood Cancer 2022;:e29754. [PMID: 35484989 DOI: 10.1002/pbc.29754] [Reference Citation Analysis]
15 Sarmiento AMA, Parulan MAA, Agbay RLMC. Rosai-Dorfman disease mimicking cavernous hemangioma: a case report. Orbit 2022;:1-5. [PMID: 35467463 DOI: 10.1080/01676830.2022.2055086] [Reference Citation Analysis]
16 Bueno HF, Agarwalla PK, Chundury A, Baisre de Leon A, Mirani N, Nimchinsky EA. Differentiation of intracranial Rosai‐Dorfman histiocytosis from meningioma using MR perfusion. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5737] [Reference Citation Analysis]
17 Tang M, Gu X, Wu P, Yang X. Clinicopathological and Gene Mutation Analysis of 27 Cases with Extranodal Rosai–Dorfman Disease. JIR 2022;Volume 15:2775-87. [DOI: 10.2147/jir.s365098] [Reference Citation Analysis]
18 Betini N, Munger AM, Rottmann D, Haims A, Costa J, Lindskog DM, Kawaguchi Y. Rare Presentation of Rosai-Dorfman Disease in Soft Tissue: Diagnostic Findings and Surgical Treatment. Case Reports in Surgery 2022;2022:1-6. [DOI: 10.1155/2022/8440836] [Reference Citation Analysis]
19 Tan MH, Foo CH, Ohn MH, Ohn KM. Experience of diagnosing and managing a patient with spinal Rosai-Dorfman-Destombes disease in a tuberculosis hyperendemic region. BMJ Case Rep 2022;15:e245360. [PMID: 35321909 DOI: 10.1136/bcr-2021-245360] [Reference Citation Analysis]
20 Ferry JA. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hematolymphoid Proliferations and Neoplasia. Head Neck Pathol 2022. [PMID: 35312979 DOI: 10.1007/s12105-022-01411-2] [Reference Citation Analysis]
21 Nasany RA, Reiner AS, Francis JH, Abla O, Panageas KS, Diamond EL. Rosai-Dorfman-Destombes disease of the nervous system: a systematic literature review. Orphanet J Rare Dis 2022;17:92. [PMID: 35236371 DOI: 10.1186/s13023-022-02220-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Lambdin J, Phillips JK, Kima ED, Paal E, Nava VE, Duncan J. Rosai-Dorfman Disease of the Rectum: Newly Identified Genetic Point Mutations and Robotic Resection. The American Surgeon. [DOI: 10.1177/00031348211069800] [Reference Citation Analysis]
23 Wang J, Wang Y, Li G, Wang C, Yu G, Sun Y. Rosai-Dorfman disease originating from nasal septal mucosa and presenting with nasal dorsum collapse: A case report with literature review. Ear Nose Throat J 2022;:1455613221079500. [PMID: 35171732 DOI: 10.1177/01455613221079500] [Reference Citation Analysis]
24 Liu T, Cai HC, Cai H, Chen M, Zhang W, Li J, Zhou DB, Cao XX. Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis. Orphanet J Rare Dis 2022;17:39. [PMID: 35130950 DOI: 10.1186/s13023-022-02193-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Negishi K, Ishihara M, Adachi S, Komori T, Achiha T, Goto T, Nishio M. Primary histiocytic sarcoma of the central nervous system: A case report. Interdisciplinary Neurosurgery 2022;28:101522. [DOI: 10.1016/j.inat.2022.101522] [Reference Citation Analysis]
26 Jheeta AS, Nayagam JS, Zen Y, Joshi D. A Case of Rosai-Dorfman Disease Mimicking Immunoglobulin G4-Related Autoimmune Pancreatitis. Pancreas 2021;50:e84-5. [PMID: 35041350 DOI: 10.1097/MPA.0000000000001945] [Reference Citation Analysis]
27 Garces S, Medeiros LJ, Marques-Piubelli ML, Coelho Siqueira SA, Miranda RN, Cuglievan B, Sriganeshan V, Medina AM, Garces JC, Saluja K, Bhattacharjee MB, Khoury JD, Li S, Xu J, Jelloul FZ, Thakral B, Cameron Yin C. Cyclin D1 expression in Rosai-Dorfman disease: A near constant finding that is not invariably associated with MAPK/ERK pathway activation. Hum Pathol 2022:S0046-8177(21)00221-5. [PMID: 34995673 DOI: 10.1016/j.humpath.2021.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Synghal G, Bhavan R, Jain SK, Oza UD. Rosai-Dorfman disease in a symptomatic elderly man. Proc (Bayl Univ Med Cent) 2022;35:78-9. [PMID: 34970042 DOI: 10.1080/08998280.2021.1957381] [Reference Citation Analysis]
29 Vaquier L, Abitbol C, Emile J, Dossier A, Guyard A, Hourseau M. Histiocytose de Rosai-Dorfman-Destombes extra-ganglionnaire du maxillaire : à propos d’un cas et revue de la littérature. Annales de Pathologie 2022. [DOI: 10.1016/j.annpat.2021.12.006] [Reference Citation Analysis]
30 Doglioni C. Rosai-Dorfman disease. A legacy of Professor Rosai that is still not exploited completely. Pathologica 2021;113:388-95. [PMID: 34837097 DOI: 10.32074/1591-951X-548] [Reference Citation Analysis]
31 Lee C, Choi N, Lee Y, Park JH, Son YI. A Case of Nasal Cavity and Laryngeal Involvement of Rosai-Dorfman Disease. Ear Nose Throat J 2021;:1455613211054632. [PMID: 34841915 DOI: 10.1177/01455613211054632] [Reference Citation Analysis]
32 Alzahem TA, Cruz AA, Maktabi AMY, Chahud F, Alkatan H. Ophthalmic Rosai-Dorfman disease: a multi-centre comprehensive study. BMC Ophthalmol 2021;21:404. [PMID: 34814862 DOI: 10.1186/s12886-021-02173-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Virk HS, Shahlaie K, Ramani B, Perry A, Fragoso R, Tuscano J, Liu YA. Orbital Rosai–Dorfman Disease Presenting as Optic Neuritis. Journal of Neuro-Ophthalmology 2022;42:e293-6. [DOI: 10.1097/wno.0000000000001405] [Reference Citation Analysis]
34 Kim S, Gray AL, Lao WP, Perez MN, Liu Y, Lee SC. Is it Anaplastic Thyroid Cancer, Primary Thyroid Lymphoma, or Rosai Dorfman Disease? An Elusive Histopathologic Diagnosis of a Thyroid Mass. Head Neck Pathol 2021. [PMID: 34755265 DOI: 10.1007/s12105-021-01392-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Liu T, Cao X. Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report. Ann Hematol 2021. [PMID: 34741628 DOI: 10.1007/s00277-021-04719-1] [Reference Citation Analysis]
36 Ward TE, Meirick T, Reiss B, Stacey AW. Regression of Intraocular Rosai- Dorfman Disease Following Treatment with Photodynamic Therapy. Ophthalmic Surg Lasers Imaging Retina 2021;52:568-71. [PMID: 34661466 DOI: 10.3928/23258160-20210905-01] [Reference Citation Analysis]
37 Nguyen PX, Nguyen NV, Le TD. Spinal extranodal Rosai-Dorfman disease: A case report and literature review. Int J Surg Case Rep 2021;88:106491. [PMID: 34656927 DOI: 10.1016/j.ijscr.2021.106491] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Zhou X, Zhang R, He J, Hu H. Rosai-Dorfman disease of the lumbar region: A case report. Asian J Surg 2021:S1015-9584(21)00563-7. [PMID: 34635408 DOI: 10.1016/j.asjsur.2021.08.060] [Reference Citation Analysis]
39 McClain KL, Bigenwald C, Collin M, Haroche J, Marsh RA, Merad M, Picarsic J, Ribeiro KB, Allen CE. Histiocytic disorders. Nat Rev Dis Primers 2021;7:73. [PMID: 34620874 DOI: 10.1038/s41572-021-00307-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
40 Leba CT, Seeley EJ, Bhakta NR, Block BL. A Woman with One Year of Cough Presumed to Be Asthma. Ann Am Thorac Soc 2021;18:1733-7. [PMID: 34596494 DOI: 10.1513/AnnalsATS.202103-395CC] [Reference Citation Analysis]
41 Emile JF, Vaglio A, Cohen-Aubart F, Haroche J. IgG4-related disease and Rosai-Dorfman-Destombes disease - Authors' reply. Lancet 2021;398:1214-5. [PMID: 34600621 DOI: 10.1016/S0140-6736(21)01811-0] [Reference Citation Analysis]
42 Civit JJR, Godoy D, Conde A, Arencibia J, Medel R, Limeres MA, Miguel IS, Marín JD, Aguilar Y, Tresserra F, Medina F. Orbital histiocytosis with systemic involvement: A case with complex affiliations. Saudi J Ophthalmol 2020;34:319-23. [PMID: 34527883 DOI: 10.4103/1319-4534.322613] [Reference Citation Analysis]
43 Hoyo-Muñoz A, Collado-Borrell R, Escudero-Vilaplana V, Bastos-Oreiro M, Herranz-Alonso A, Sanjurjo-Sáez M. Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease. J Clin Pharm Ther 2021. [PMID: 34514634 DOI: 10.1111/jcpt.13513] [Reference Citation Analysis]
44 Roosta Y, Esfahani A, Vahedi A, Tarvirizadeh K, Asoubar S, Boroofeh B, Dinparast R, Behzadi F, Raeisi M, Hosseiniazar MM. Rosai-Dorfman disease presenting with solitary liver mass without lymphadenopathy: A case report. Clin Case Rep 2021;9:e04709. [PMID: 34466261 DOI: 10.1002/ccr3.4709] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Choo PZQ, Loh AHL, Selvarajan S, Tan PH, Tan VKM, Yong WS, Leong LCH. Breast-related extranodal Rosai-Dorfman disease presenting as subcutaneous masses with thick hyperechoic rim, with review of the literature. Breast J 2021. [PMID: 34467595 DOI: 10.1111/tbj.14286] [Reference Citation Analysis]
46 Yu L, Deng Z, Cai L, Chen Q. Primary Rosai-Dorfman disease of tibia: A case report. Asian J Surg 2021:S1015-9584(21)00450-4. [PMID: 34330584 DOI: 10.1016/j.asjsur.2021.07.035] [Reference Citation Analysis]
47 Nóbrega PR, Rodrigues PGB, de Sousa Pereira I, de Figueiredo Santos C, Gerson G, de Arruda JAM, Júnior JWLT, de Araújo Coimbra PP, Braga-Neto P. Steroid responsive cavernous sinus syndrome due to Rosai-Dorfman disease: beyond Tolosa-Hunt syndrome - a case report. BMC Neurol 2021;21:264. [PMID: 34225703 DOI: 10.1186/s12883-021-02255-z] [Reference Citation Analysis]
48 Blatt J, Parekh P, Powell BC, Fedoriw Y, Reddy I, Montgomery ND. Rosai-Dorfman Disease and Exocrine Pancreatic Insufficiency in a Patient With a Germline SLC29A3 Mutation. J Pediatr Hematol Oncol 2021;43:e689-91. [PMID: 32769566 DOI: 10.1097/MPH.0000000000001889] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Riller Q, Rieux-Laucat F. RASopathies: from germline mutations to somatic and multigenic diseases. Biomed J 2021:S2319-4170(21)00070-6. [PMID: 34175492 DOI: 10.1016/j.bj.2021.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
50 Gawdzik A, Ziarkiewicz-Wróblewska B, Chlebicka I, Jankowska-Konsur A, Szepietowski JC, Maj J. Cutaneous Rosai-Dorfman Disease: A Treatment Challenge. Dermatol Ther (Heidelb) 2021;11:1443-8. [PMID: 34143402 DOI: 10.1007/s13555-021-00557-1] [Reference Citation Analysis]
51 Wu GJ, Li BB, Zhu RL, Yang CJ, Chen WY. Rosai-Dorfman disease with lung involvement in a 10-year-old patient: A case report. World J Clin Cases 2021; 9(17): 4285-4293 [PMID: 34141792 DOI: 10.12998/wjcc.v9.i17.4285] [Reference Citation Analysis]
52 Razanamahery J, Humbert S, Emile JF, Cohen-Aubart F, Fontan J, Maksud P, Audia S, Haroche J. Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review. Front Med (Lausanne) 2021;8:678456. [PMID: 34222286 DOI: 10.3389/fmed.2021.678456] [Reference Citation Analysis]
53 Gulati N, Allen CE. Langerhans cell histiocytosis: Version 2021. Hematol Oncol 2021;39 Suppl 1:15-23. [PMID: 34105821 DOI: 10.1002/hon.2857] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
54 Saleem A, Hoffmann J, Warnke R, Rieger KE, Longacre T. Intralymphatic Rosai-Dorfman Disease Associated With Vulvar Lymphedema: A Case Report of an Extremely Rare Phenomenon. Int J Gynecol Pathol 2020;39:443-6. [PMID: 31274698 DOI: 10.1097/PGP.0000000000000619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Thomas KD, Delahoussaye P, Schwartz MR, Ayala AG, Ro JY. Extranodal Rosai-Dorfman disease involving soft tissue associated with increased IgG4 plasma cells. Human Pathology: Case Reports 2021;24:200488. [DOI: 10.1016/j.ehpc.2021.200488] [Reference Citation Analysis]
56 Cohen Aubart F, Idbaih A, Emile JF, Amoura Z, Abdel-Wahab O, Durham BH, Haroche J, Diamond EL. Histiocytosis and the nervous system: from diagnosis to targeted therapies. Neuro Oncol 2021:noab107. [PMID: 33993305 DOI: 10.1093/neuonc/noab107] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
57 Giuffrè C, Giuffrè G. Choroidal involvement in Rosai-Dorfman disease successfully treated with cobimetinib. Indian J Ophthalmol 2020;68:2051-3. [PMID: 32823478 DOI: 10.4103/ijo.IJO_1359_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Kobayashi KR, Hajiyev Y, Fuller MY, Orman G, Lambert EM. Presentation of External Ear Rosai-Dorfman Disease With Laryngeal Involvement. Ear Nose Throat J 2021;:1455613211016704. [PMID: 33973483 DOI: 10.1177/01455613211016704] [Reference Citation Analysis]
59 Chakraborty R, Abdel-Wahab O, Durham BH. MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age. Cold Spring Harb Perspect Med 2021;11:a034892. [PMID: 32601132 DOI: 10.1101/cshperspect.a034892] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
60 Zhao EJ, Cheng CV, Mattman A, Chen LYC. Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management. Lancet Haematol 2021;8:e365-75. [PMID: 33894171 DOI: 10.1016/S2352-3026(21)00056-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
61 Wu KJ, Li SH, Liao JB, Chiou CC, Wu CS, Chen CC. NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study. Biology (Basel) 2021;10:396. [PMID: 34063325 DOI: 10.3390/biology10050396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
62 Choi JH, Ro JY. The 2020 WHO Classification of Tumors of Bone: An Updated Review. Adv Anat Pathol 2021;28:119-38. [PMID: 33480599 DOI: 10.1097/PAP.0000000000000293] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 25.0] [Reference Citation Analysis]
63 Emile JF, Cohen-Aubart F, Collin M, Fraitag S, Idbaih A, Abdel-Wahab O, Rollins BJ, Donadieu J, Haroche J. Histiocytosis. Lancet 2021;398:157-70. [PMID: 33901419 DOI: 10.1016/S0140-6736(21)00311-1] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
64 Haghighat Jahromi A, Goodman AM, Hoh CK. Rosai-Dorfman-Destombes (RDD) disease presenting as palindromic rheumatism. BMC Med Imaging 2021;21:72. [PMID: 33858362 DOI: 10.1186/s12880-021-00596-2] [Reference Citation Analysis]
65 Tummidi S, Singh HK, Reddy PA, Sindhura M, Kosaraju N, Shankaralingappa A, Kumar NP. ROSE in Rosai-Dorfman-Destombes (RDD) disease: a cytological diagnosis. Eur J Med Res 2021;26:34. [PMID: 33849657 DOI: 10.1186/s40001-021-00505-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Gilani K, Kuntz S, Munoz DG, Schneider R. Pearls & Oy-sters: Rosai-Dorfman Disease of the Central Nervous System. Neurology 2021:10. [PMID: 33849989 DOI: 10.1212/WNL.0000000000012035] [Reference Citation Analysis]
67 Lee M, Ryu KH, Baek HJ, Moon JI, Yoon S, An HJ, Nam IC. Rosai-Dorfman disease with infiltration of IgG4-bearing plasma cells presenting as laryngeal-nasal masses and cervical lymphadenopathy: A case report. Medicine (Baltimore) 2021;100:e25165. [PMID: 33761691 DOI: 10.1097/MD.0000000000025165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Kashima J, Yoshida M, Jimbo K, Izutsu K, Ushiku T, Yonemori K, Yoshida A. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology. Am J Surg Pathol 2021;45:347-55. [PMID: 32826530 DOI: 10.1097/PAS.0000000000001567] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
69 Auerbach A, Schmieg JJ, Aguilera NS. Pediatric Lymphoid and Histiocytic Lesions in the Head and Neck. Head Neck Pathol 2021;15:41-58. [PMID: 33723759 DOI: 10.1007/s12105-020-01257-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Singh A, Simons Y, Biren-Fetz J, Mohapatra G, Ni H, Gaitonde S, Khan I. Extended treatment response to imatinib in Rosai-Dorfman disease. Eur J Haematol 2021;106:868-70. [PMID: 33619765 DOI: 10.1111/ejh.13605] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Yang J, Newbury R, Malicki D, Crawford JR. Rare case of extranodal Rosai-Dorfman disease presenting as a middle cranial fossa tumour. BMJ Case Rep 2021;14:e241537. [PMID: 33653869 DOI: 10.1136/bcr-2020-241537] [Reference Citation Analysis]
72 Vithran DTA, Wang JZ, Xiang F, Wen J, Xiao S, Tang WZ, Chen Q. Osseous Rosai-Dorfman disease of tibia in children: A case report. World J Clin Cases 2021; 9(6): 1416-1423 [PMID: 33644210 DOI: 10.12998/wjcc.v9.i6.1416] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
73 Swor K, Zutshi D, Dubey E, Gonik B. Pregnant patient with extranodal CNS Rosai-Dorfman disease with new-onset seizures: the conundrum of differentiating disease progression from eclampsia. BMJ Case Rep 2021;14:e239427. [PMID: 33602767 DOI: 10.1136/bcr-2020-239427] [Reference Citation Analysis]
74 Ravindran A, Goyal G, Go RS, Rech KL; Mayo Clinic Histiocytosis Working Group. Rosai-Dorfman Disease Displays a Unique Monocyte-Macrophage Phenotype Characterized by Expression of OCT2. Am J Surg Pathol 2021;45:35-44. [PMID: 33177341 DOI: 10.1097/PAS.0000000000001617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
75 Deshayes R, Eustache M, Moreau A, Péterlin P, Néel A, Masseau A, Bodet-Milin C, Hamidou M. [Systemic Rosai-Dorfman-Destombes disease associated with a myelodysplastic syndrome. Efficacy of hematologic treatment]. Rev Med Interne 2021;42:281-4. [PMID: 33485702 DOI: 10.1016/j.revmed.2021.01.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Razanamahery J, Dresco F, Emile JF, Verhoeven F, Algros MP, Lodovichetti J, Humbert S, Bouiller K, Magy-Bertrand N. Sacroiliitis in a patient with Rosai-Dorfman disease: new bone location or overlap with axial spondylarthritis? Rheumatology (Oxford) 2020;59:2168-70. [PMID: 31943104 DOI: 10.1093/rheumatology/kez675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 McClain KL. Histiocytic Diseases of Neonates: Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, and Juvenile Xanthogranuloma. Clin Perinatol 2021;48:167-79. [PMID: 33583503 DOI: 10.1016/j.clp.2020.11.008] [Reference Citation Analysis]
78 Putzeys CC, Hardee S, Jinadu L, Pugmire B, Fernández KS. Rosai-Dorfman-Destombes Disease as First Manifestation of Systemic Lupus Erythematosus. J Pediatr Hematol Oncol 2020;42:452-3. [PMID: 32118815 DOI: 10.1097/MPH.0000000000001754] [Reference Citation Analysis]
79 Nieto-Benito LM, Suárez-Fernández RM, Baniandrés-Rodríguez O. Intralesional methotrexate used in cutaneous Rosai-Dorfman disease. Med Clin (Barc) 2020;155:564-5. [PMID: 31759691 DOI: 10.1016/j.medcli.2019.09.014] [Reference Citation Analysis]
80 Steinke J, Nadalin S, Horger MS, Fend F, Frauenfeld L. [Rosai-Dorfman disease as a rare cause of a pancreatic mass]. Pathologe 2021;42:231-4. [PMID: 33306139 DOI: 10.1007/s00292-020-00877-7] [Reference Citation Analysis]
81 Rouillé E, Bilbault H, Levin C, Lezmi S. Characterization of an interdigitating dendritic cell hyperplasia case in a lymph node of a control C57BL/6 mouse. J Toxicol Pathol 2021;34:101-6. [PMID: 33627950 DOI: 10.1293/tox.2020-0039] [Reference Citation Analysis]
82 Riccio L, Donofrio CA, Serio G, Melatini A. Malignant behaviour of primary intracranial Rosai Dorfman disease: A rare presentation of a benign disease. Neurochirurgie 2021;67:205-9. [PMID: 33276004 DOI: 10.1016/j.neuchi.2020.11.006] [Reference Citation Analysis]
83 Donati M, Nosek D, Waldenbäck P, Martinek P, Jonsson BA, Galgonkova P, Hawawrehova M, Berouskova P, Kastnerova L, Persichetti P, Crescenzi A, Michal M, Kazakov DV. MAP2K1-Mutated Melanocytic Neoplasms With a SPARK-Like Morphology. Am J Dermatopathol 2021;43:412-7. [PMID: 33264134 DOI: 10.1097/DAD.0000000000001840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
84 Zhang Y, Liu J, Zhu J, Zhou X, Zhang K, Wang S, Ma W, Pan H, Wang R, Zhu H, Yao Y. Case Report: Rosai-Dorfman Disease Involving Sellar Region in a Pediatric Patient: A Case Report and Systematic Review of Literature. Front Med (Lausanne) 2020;7:613756. [PMID: 33330575 DOI: 10.3389/fmed.2020.613756] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
85 Wilson NR, Fang H, Loghavi S, Wang W, Tang G, Haltom RO, Rausch CR, McClain KL, Rao KV, Popat UR, Fayad LE, Champa N, Calvo KR, Allen CE, Kadia TM, Pemmaraju N. Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation. Br J Haematol 2021;192:667-71. [PMID: 33238033 DOI: 10.1111/bjh.17258] [Reference Citation Analysis]
86 Kondo T, Takahashi M, Yamasaki G, Sugimoto M, Kuse A, Morichika M, Nakagawa K, Sakurada M, Asano M, Ueno Y. Autopsy case of Rosai-Dorfman disease presenting as fibrinous pericarditis. Leg Med (Tokyo) 2021;48:101812. [PMID: 33227653 DOI: 10.1016/j.legalmed.2020.101812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Poldemann JJ, Hinrichs BH, Makramalla A. Unique Presentation of Rosai-Dorfman Disease as Concomitant Appendiceal and Rectal Masses with IgG4-Positive Plasma Cells Diagnosed by Core Needle Biopsy. Case Rep Oncol Med 2020;2020:8814871. [PMID: 33133711 DOI: 10.1155/2020/8814871] [Reference Citation Analysis]
88 Anbardar MH, Hamzehloo S, Fazeli F, Zareifar S, Imanieh MH, Bahmanzadegan Jahromi M, Ghorbani AM. Rosai-Dorfman disease: a rare presentation with para-aortic and mesenteric lymphadenopathy, hepatosplenomegaly and ascites. Surg Exp Pathol 2020;3. [DOI: 10.1186/s42047-020-00076-x] [Reference Citation Analysis]
89 Noggle E, Ortanca I, Clark I, Yadak N, Glazer ES. Synchronous Colon and Pancreatic Rosai-Dorfman Disease. Am Surg 2021;87:486-91. [PMID: 33054323 DOI: 10.1177/0003134820950294] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
90 Roe CJ, Tracht J, Madrigal E, Krasinskas AM, Xue Y. Rosai-Dorfman disease of the pancreas: Cytologic analysis of three cases presenting as pancreatic masses. Diagn Cytopathol 2021;49:E181-6. [PMID: 33058558 DOI: 10.1002/dc.24638] [Reference Citation Analysis]
91 Jafri ZA, Reddy SP, Cassarino DS. KRAS 117N positive Rosai-Dorfman disease with atypical features. J Cutan Pathol 2021;48:147-50. [PMID: 32974961 DOI: 10.1111/cup.13883] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Poyiadji N, Li T, Craig J, Rheinboldt M, Patel S, Marin H, Griffith B. Imaging Findings in Non-Neoplastic Sinonasal Disease: Review of Imaging Features With Endoscopic Correlates. Curr Probl Diagn Radiol 2020:S0363-0188(20)30183-3. [PMID: 33039195 DOI: 10.1067/j.cpradiol.2020.09.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Bonometti A; for Associazione Italiana Ricerca Istiocitosi AIRI ONLUS. The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification. Leuk Lymphoma 2021;62:32-44. [PMID: 32969291 DOI: 10.1080/10428194.2020.1824070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Mahajan S, Nakajima R, Yabe M, Dogan A, Ulaner GA, Yahalom J, Noy A, Diamond EL, Schöder H. Rosai-Dorfman Disease-Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up. Clin Nucl Med 2020;45:e260-6. [PMID: 32349088 DOI: 10.1097/RLU.0000000000003014] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
95 Vaidya T, Mahajan A, Rane S. Multimodality imaging manifestations of Rosai-Dorfman disease. Acta Radiol Open 2020;9:2058460120946719. [PMID: 32884838 DOI: 10.1177/2058460120946719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
96 Salama HA, Jazieh AR, Alhejazi AY, Absi A, Alshieban S, Alzahrani M, Alaskar A, Gmati G, Damlaj M, Abuelgasim KA, Alghamdi A, Alahmari B, Almugairi A, Alzahrani H, Bazarbachi A, Musa MOH, Goyal G. Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis. Clin Lymphoma Myeloma Leuk 2021;21:e66-75. [PMID: 32943371 DOI: 10.1016/j.clml.2020.08.007] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
97 Schleinitz N, Briantais A, Ebbo M. [IgG4-related disease: Diagnostic criteria evolution toward the 2019 ACR/EULAR classification criteria]. Rev Med Interne 2020;41:814-21. [PMID: 32732082 DOI: 10.1016/j.revmed.2020.06.015] [Reference Citation Analysis]
98 González-pacheco H, Salas-villela RA, Carmona-levario P, Manzur-sandoval D, Mora-cervantes R, Palma-carbajal R, Arias-mendoza A. Electrical Storm in a Patient With Rosai–Dorfman Disease With Intracardiac Masses and Myocardial Infiltration. Canadian Journal of Cardiology 2020;36:1326.e13-5. [DOI: 10.1016/j.cjca.2020.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Kim JY, Shim HK, Kim MR. A Case of Extranodal Rosai-Dorfman Disease Presenting as an Isolated Mass on the Base of the Tongue in a 57-Year-old Woman. Am J Case Rep 2020;21:e925716. [PMID: 32776915 DOI: 10.12659/AJCR.925716] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Iyengar NS, Golub D, McQuinn MW, Hill T, Tang K, Gardner SL, Harter DH, Sen C, Staffenberg DA, Thomas K, Elkin Z, Belinsky I, William C. Orbital Rosai-Dorfman disease initially diagnosed as IgG4-related disease: a case report. Acta Neuropathol Commun 2020;8:113. [PMID: 32682450 DOI: 10.1186/s40478-020-00995-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Ramon A, Morel H, Piroth C, Maillefert JF. A spontaneous bone reconstruction. Rheumatology (Oxford) 2020;59:1586. [PMID: 31620793 DOI: 10.1093/rheumatology/kez485] [Reference Citation Analysis]
102 Bruce-Brand C, Schneider JW, Schubert P. Rosai-Dorfman disease: an overview. J Clin Pathol. 2020;73:697-705. [PMID: 32591351 DOI: 10.1136/jclinpath-2020-206733] [Cited by in Crossref: 14] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
103 Mastropolo R, Close A, Allen SW, McClain KL, Maurer S, Picarsic J. BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor. Blood Adv 2019;3:1848-53. [PMID: 31213430 DOI: 10.1182/bloodadvances.2019000093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
104 Petraglia AF, Davick JJ, Mandell JW, Lapides DA. Rosai-Dorfman Disease: A Less Common Cause of Leptomeningeal and Nerve Root Enhancement. Neurohospitalist 2020;10:309-13. [PMID: 32983353 DOI: 10.1177/1941874420929187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 Bonometti A, Berti E; for Associazione Italiana Ricerca Istiocitosi ONLUS. Reticulohistiocytoses: a revision of the full spectrum. J Eur Acad Dermatol Venereol 2020;34:1684-94. [PMID: 31955466 DOI: 10.1111/jdv.16214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
106 Boissaud-cooke MA, Bhatt K, Hilton DA, Muquit S. Isolated Intracranial Rosai-Dorfman Disease: Case Report and Review of the Literature. World Neurosurgery 2020;137:239-42. [DOI: 10.1016/j.wneu.2020.01.229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
107 Tracht J, Reid MD, Xue Y, Madrigal E, Sarmiento JM, Kooby D, Alese OB, Krasinskas AM. Rosai-Dorfman Disease of the Pancreas Shows Significant Histologic Overlap With IgG4-related Disease. Am J Surg Pathol 2019;43:1536-46. [PMID: 31368911 DOI: 10.1097/PAS.0000000000001334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
108 Mohammadi O, Zylberglait Lisigurski M, Mehra D, Pishdad R, Gulec S. Rosai-Dorfman Disease and Unusual Local Invasive Presentation. Cureus 2020;12:e7328. [PMID: 32313769 DOI: 10.7759/cureus.7328] [Reference Citation Analysis]
109 Martin-Marcuartu JJ, Moreno-Caballero M, Nava Mateos JJ, Barquilla Cordero P, Arenas Ore R, Martínez-Esteve A. Inusual case of Rosai-Dorfman disease in a 18F-FDG PET/CT study. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2020;39:108-9. [PMID: 32029412 DOI: 10.1016/j.remn.2019.12.005] [Reference Citation Analysis]
110 Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, Nowakowski GS, Thanarajasingam G, Habermann TM, Vassallo R, Sher T, Parikh SA, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group. Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease. Haematologica 2020;105:348-57. [PMID: 31004029 DOI: 10.3324/haematol.2019.219626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 35] [Article Influence: 11.5] [Reference Citation Analysis]
111 Shetty S, Sharma N, Booth CN, Oshilaja O, Downs-Kelly EP, McKenney JK, Sturgis CD. Mammary Extranodal Rosai-Dorfman Disease With and Without Associated Axillary Lymphadenopathy: Insights for Practitioners of Breast Pathology. Int J Surg Pathol 2020;28:541-8. [PMID: 31992097 DOI: 10.1177/1066896920901770] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Sharma A, Hemrajani D, Singh S, Bhardwaj K, Bhandari C, Jenaw RK. Rosai-Dorfman disease presenting as internal jugular vein thrombosis and middle lobe collapse-consolidation. Lung India 2020;37:433-6. [PMID: 32883905 DOI: 10.4103/lungindia.lungindia_150_19] [Reference Citation Analysis]
113 Namoglu EC, Hughes ME, Plastaras JP, Landsburg DJ, Maity A, Nasta SD. Management and outcomes of sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman Disease). Leuk Lymphoma 2020;61:905-11. [PMID: 31876204 DOI: 10.1080/10428194.2019.1703971] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Alwani MM, Elghouche AN, Schueth EA, Campiti VJ, Matt BH, Yekinni AO. Manifestations of Pediatric Extranodal Rosai Dorfman Disease in the head and neck. Int J Pediatr Otorhinolaryngol 2020;131:109851. [PMID: 31901484 DOI: 10.1016/j.ijporl.2019.109851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
115 Rajyalakshmi R, Akhtar M, Swathi Y, Chakravarthi R, Bhaskara Reddy J, Beulah Priscilla M. Cytological Diagnosis of Rosai-Dorfman Disease: A Study of Twelve Cases with Emphasis on Diagnostic Challenges. J Cytol 2020;37:46-52. [PMID: 31942098 DOI: 10.4103/JOC.JOC_4_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
116 Desai CK, Hayes SN, Shah MV, Maleszewski JJ, Bleeker J, Steffen K, Stys M. Extranodal Rosai-Dorfman Disease Presenting as a Pericardial Mass and Constrictive Pericarditis. JACC Case Rep 2019;1:643-7. [PMID: 34316897 DOI: 10.1016/j.jaccas.2019.10.011] [Reference Citation Analysis]
117 Dhillon N, Skinnider B, Darabian S, Carruthers M. Histiocytosis masquerading in the mesentery and pleura. BMJ Case Rep 2019;12:e232165. [PMID: 31791991 DOI: 10.1136/bcr-2019-232165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Subhadarshani S, Kumar T, Arava S, Gupta S. Rosai-Dorfman disease with cutaneous plaques and autoimmune haemolytic anemia. BMJ Case Rep 2019;12:e231927. [PMID: 31767610 DOI: 10.1136/bcr-2019-231927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
119 Picarsic J, Pysher T, Zhou H, Fluchel M, Pettit T, Whitehead M, Surrey LF, Harding B, Goldstein G, Fellig Y, Weintraub M, Mobley BC, Sharples PM, Sulis ML, Diamond EL, Jaffe R, Shekdar K, Santi M. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease. Acta Neuropathol Commun 2019;7:168. [PMID: 31685033 DOI: 10.1186/s40478-019-0811-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
120 Moyon Q, Boussouar S, Maksud P, Emile JF, Charlotte F, Aladjidi N, Prévot G, Donadieu J, Amoura Z, Grenier P, Haroche J, Cohen Aubart F. Lung Involvement in Destombes-Rosai-Dorfman Disease: Clinical and Radiological Features and Response to the MEK Inhibitor Cobimetinib. Chest 2020;157:323-33. [PMID: 31669429 DOI: 10.1016/j.chest.2019.09.036] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
121 Golwala ZM, Taur P, Pandrowala A, Chandak S, Desai M. Sirolimus-A targeted therapy for Rosai-Dorfman disease. Pediatr Blood Cancer 2019;66:e27994. [PMID: 31524314 DOI: 10.1002/pbc.27994] [Reference Citation Analysis]
122 Lin CK, Tsai YD. Nonresectable Thoracic Rosai-Dorfman Disease: A Case Report and Review of the Literature. World Neurosurg 2019;132:309-13. [PMID: 31525482 DOI: 10.1016/j.wneu.2019.09.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
123 Fu WJ, Du J, Lu J, Wang LZ, Yang JM, He MX, Hu XX. [Rosai-Dorfman disease: a clinicopathologic analysis and whole exome sequencing in 23 cases]. Zhonghua Xue Ye Xue Za Zhi 2019;40:656-61. [PMID: 31495132 DOI: 10.3760/cma.j.issn.0253-2727.2019.08.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 McCarthy S, Neville G, Clover AJP, Heffron CCBB, Murphy LA. A facial nodule. Clin Exp Dermatol 2020;45:373-5. [PMID: 31478215 DOI: 10.1111/ced.14058] [Reference Citation Analysis]
125 Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Mayo Clin Proc 2019;94:2054-71. [PMID: 31472931 DOI: 10.1016/j.mayocp.2019.02.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 47] [Article Influence: 10.7] [Reference Citation Analysis]
126 Khera D, Elhence P, Khera PS. An unusual cause of lymphadenopathy in a child. BMJ Case Rep 2019;12:e230436. [PMID: 31326910 DOI: 10.1136/bcr-2019-230436] [Reference Citation Analysis]
127 Lee YK, Chao SC, Lee CN, Hung JH. Scleritis and anterior uveitis may herald the development of an epibulbar tumor in patients with extranodal Rosai-Dorfman disease: a case report. BMC Ophthalmol 2019;19:144. [PMID: 31291929 DOI: 10.1186/s12886-019-1158-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
128 Sathyanarayanan V, Issa A, Pinto R, Fayad LE, Loghavi S, Hagemeister F, Westin JR. Rosai-Dorfman Disease: The MD Anderson Cancer Center Experience. Clin Lymphoma Myeloma Leuk 2019;19:709-14. [PMID: 31446000 DOI: 10.1016/j.clml.2019.06.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Mcintire PJ, Kilic AI, Chen HH, Atieh M, Wojcik EM, Pambuccian SE. Fine-needle aspiration specimens of 3 cases of intra-abdominal Rosai-Dorfman disease with comprehensive review of the literature. Journal of the American Society of Cytopathology 2019;8:190-205. [DOI: 10.1016/j.jasc.2019.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
130 Furia S, Nannini N, Pascarella A, Breda C. Mediastinal Rosai-Dorfman Disease With Widespread Lesions: When Surgical Biopsy Is Needed. Ann Thorac Surg 2020;109:e45-7. [PMID: 31207246 DOI: 10.1016/j.athoracsur.2019.04.089] [Reference Citation Analysis]
131 Facchetti F, Lonardi S, Vermi W, Lorenzi L. Updates in histiocytic and dendritic cell proliferations and neoplasms. Diagnostic Histopathology 2019;25:217-28. [DOI: 10.1016/j.mpdhp.2019.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
132 Lopetegui-Lia N, Asad SD, Jafri SI, Harrison JS. Autoimmune Diseases and Rosai-Dorfman Disease Coexist More Commonly than Expected: Two Case Reports. Am J Case Rep 2019;20:770-2. [PMID: 31147530 DOI: 10.12659/AJCR.915627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
133 Razanamahery J, Diamond EL, Cohen-Aubart F, Plate KH, Lourida G, Charlotte F, Hélias-Rodzewicz Z, Goyal G, Go RS, Dogan A, Abdel-Wahab O, Durham B, Ozkaya N, Amoura Z, Emile JF, Haroche J. Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1. Haematologica 2020;105:e5-8. [PMID: 31123032 DOI: 10.3324/haematol.2019.216937] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
134 Diamond EL, Durham BH, Ulaner GA, Drill E, Buthorn J, Ki M, Bitner L, Cho H, Young RJ, Francis JH, Rampal R, Lacouture M, Brody LA, Ozkaya N, Dogan A, Rosen N, Iasonos A, Abdel-Wahab O, Hyman DM. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature. 2019;567:521-524. [PMID: 30867592 DOI: 10.1038/s41586-019-1012-y] [Cited by in Crossref: 91] [Cited by in F6Publishing: 109] [Article Influence: 30.3] [Reference Citation Analysis]
135 Bonometti A, Sacco G, De Juli E, Invernizzi R, Venegoni L, Bagnoli F, Moltrasio C, Passoni E, Bellistri F, Bianchi P, Alaibac M, Paulli M, Berti E. Multisystem non‐arthropathic reticulohistiocytosis: problems and pitfalls in the differential diagnosis of multisystem non‐Langerhans‐cell histiocytoses. J Eur Acad Dermatol Venereol 2019;33:e195-8. [DOI: 10.1111/jdv.15461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
136 Ross AB, Davis KW, Buehler D, Chan BY. Primary Rosai-Dorfman Disease of Bone: A Report of Two Cases. Case Rep Radiol 2019;2019:1720131. [PMID: 30719368 DOI: 10.1155/2019/1720131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
137 Elias J, Muglia VF. Magnetic Resonance Imaging of the Perirenal Space and Retroperitoneum. Magnetic Resonance Imaging Clinics of North America 2019;27:77-103. [DOI: 10.1016/j.mric.2018.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
138 Chen LYC, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica 2019;104:444-55. [PMID: 30705099 DOI: 10.3324/haematol.2018.205526] [Cited by in Crossref: 27] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
139 Al-Ghawas MS, Ng T, Chen LYC. Confirmed Efficacy of Lenalidomide and Dexamethasone in Unresectable Cutaneous Facial Rosai-Dorfman-Destombes Disease. Mayo Clin Proc Innov Qual Outcomes 2019;3:94-6. [PMID: 30899913 DOI: 10.1016/j.mayocpiqo.2018.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Kaddis N, Fisher D, Jacobsen ED. Cutaneous Involvement of Hematologic Malignancies. Hematol Oncol Clin North Am 2019;33:163-72. [PMID: 30497673 DOI: 10.1016/j.hoc.2018.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
141 Kumamoto T, Aoki Y, Sonoda T, Yamanishi M, Arakawa A, Sugiyama M, Shirakawa N, Ishimaru S, Saito Y, Maeshima A, Maeda M, Ogawa C. A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib. Int J Hematol 2019;109:228-32. [PMID: 30361829 DOI: 10.1007/s12185-018-2553-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
142 Whipple NS, Marion LL, Dansie DM, Murina AT, Megason GC, Vijayakumar V, Herrington BL. [18F]FDG-PET for evaluating pediatric Rosai-Dorfman disease. Pediatr Hematol Oncol 2018;35:177-80. [PMID: 30346866 DOI: 10.1080/08880018.2018.1484828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Kasonkanji E, Seguin R, Kaimila B, Dhungel BM, Painschab M, Tomoka T, Gopal S. Rosai-Dorfman disease in Malawi. Clin Case Rep 2018;6:2313-5. [PMID: 30564319 DOI: 10.1002/ccr3.1820] [Reference Citation Analysis]
144 Garces S, Yin CC, Patel KP, Khoury JD, Manning JT, Li S, Xu J, Pina-oviedo S, Johnson MR, González S, Molgó M, Ruiz-cordero R, Medeiros LJ. Focal Rosai–Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation. Mod Pathol 2019;32:16-26. [DOI: 10.1038/s41379-018-0152-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
145 Li Y, Wang X, Gao J, Yu S, Li Z. Isolated extradural Rosai-Dorfman disease causing the spinal cord compression: A case report. Medicine (Baltimore) 2018;97:e12722. [PMID: 30290681 DOI: 10.1097/MD.0000000000012722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
146 Bassa C, Tagle R, Claro E, Mendez G, Dominguez J. Rosai-Dorfman-Destombes disease with renal involvement and secondary glomerulopathy: Report of an exceptional case. Urol Case Rep 2019;22:17-8. [PMID: 30306052 DOI: 10.1016/j.eucr.2018.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]